Hotsia.Com : เที่ยวสะใจ

The Chronic Kidney Disease Solution™ By Shelly Manning It is an eBook that includes the most popular methods to care and manage kidney diseases by following the information provided in it. This easily readable eBook covers up various important topics like what is chronic kidney disease, how it is caused, how it can be diagnosed, tissue damages caused by chronic inflammation, how your condition is affected by gut biome, choices for powerful lifestyle and chronic kidney disease with natural tools etc.

---

How does tobacco cessation alter CKD trajectories, what longitudinal data show, and how does this compare with vaping cessation?

🌱 A Turning Point for the Kidneys: The Impact of Tobacco Cessation on CKD

Tobacco cessation dramatically and favorably alters the trajectory of Chronic Kidney Disease (CKD) by removing a powerful, multi-pronged assault on kidney function. Longitudinal data clearly show that quitting smoking slows the rate of kidney function decline and reduces the risk of progressing to kidney failure. While the long-term data on vaping is still emerging, the known harms of its constituents suggest that its cessation is also highly beneficial, though the comparison highlights the exceptionally toxic and well-documented nature of traditional cigarette smoke.

How Tobacco Cessation Halts the Damage

Tobacco cessation is one of the most impactful lifestyle modifications a patient with CKD can make. Smoking is a potent and independent risk factor for both the development and progression of kidney disease. Its damaging effects are systemic and direct. When a patient quits smoking, they halt several ongoing pathological processes that are actively harming their kidneys.

The first and most immediate benefit is the improvement in endothelial function. The endothelium is the delicate, single-cell-thick lining of all blood vessels, including the microscopic capillaries of the glomeruli, the kidney’s filtering units. The thousands of toxic chemicals and the massive load of oxidative stress from cigarette smoke cause severe endothelial dysfunction. This impairs the ability of the blood vessels to produce nitric oxide, a molecule essential for vasodilation (relaxation of the blood vessels). The result is increased stiffness in the renal arteries, reduced blood flow to the kidneys, and an increase in blood pressure both systemically and within the glomeruli themselves (intraglomerular hypertension). When a person quits smoking, this relentless toxic assault stops. The endothelium can begin to heal, nitric oxide production can improve, and the damaging hemodynamic stress on the kidneys is significantly reduced.

Secondly, quitting smoking drastically reduces oxidative stress and inflammation. Cigarette smoke is a major source of free radicals, which cause widespread cellular damage. This oxidative stress is a key driver of fibrosis, or scarring, in the kidneys, which is the hallmark of progressive CKD. By quitting, the patient removes this massive pro-oxidant burden, allowing the body’s natural antioxidant defense systems to recover and reducing the inflammatory processes that lead to irreversible kidney scarring.

Finally, smoking is known to worsen two of the biggest drivers of CKD: hypertension and diabetes. Smoking has an acute pressor effect, raising blood pressure, and it contributes to arterial stiffness, making chronic hypertension harder to control. It also increases insulin resistance, making it more difficult to manage blood sugar in diabetic patients. Tobacco cessation removes these aggravating factors, leading to better control of blood pressure and glucose, which in turn slows the progression of kidney damage

The Evidence Over Time: What Longitudinal Data Show

The long-term benefits of smoking cessation on CKD trajectories are not just theoretical; they are firmly established by numerous large-scale, longitudinal cohort studies that have followed patients for many years.

These studies consistently demonstrate a clear and significant difference in outcomes between patients who continue to smoke, those who quit, and those who have never smoked. For example, the Multiple Risk Factor Intervention Trial (MRFIT) and the Atherosclerosis Risk in Communities (ARIC) Study have provided powerful data on this topic. Their findings show that active smokers with CKD have the fastest rate of estimated Glomerular Filtration Rate (eGFR) decline and the highest risk of progressing to end-stage renal disease (ESRD) requiring dialysis or transplantation.

Crucially, these studies also show that former smokers have a significantly better prognosis than current smokers. The data indicates that after a person quits, their rate of eGFR decline begins to slow down, eventually approaching the rate seen in never-smokers. While the damage already done to the kidneys cannot be completely reversed, quitting effectively puts the brakes on the accelerated decline. One major study found that in patients with diabetic nephropathy, continuing to smoke was associated with a nearly doubled risk of progressing to ESRD compared to those who had quit. The message from this wealth of long-term data is unequivocal: quitting smoking is a critical, life-altering intervention that can add years of function to a person’s kidneys.

⚖️ A Modern Menace: Comparison with Vaping Cessation

When comparing the impact of tobacco cessation with vaping (e-cigarette) cessation, it is a comparison between a well-documented, severe harm and a newer, less understood but still significant threat.

Tobacco Cessation: As established, the benefits are profound and proven. Quitting smoking removes the combustion productstar, carbon monoxide, and thousands of other toxinswhich are responsible for the most severe oxidative stress and endothelial damage. The benefits of quitting traditional cigarettes are massive and undisputed.

Vaping Cessation: The role of vaping in CKD is a newer area of research, but the existing evidence is highly concerning. While e-cigarettes do not produce the same tar and carbon monoxide as combustible tobacco, they are not a harmless water vapor.

• Nicotine: The primary ingredient, nicotine, is a potent vasoconstrictor. It activates the sympathetic nervous system, acutely raises blood pressure and heart rate, and can contribute to endothelial dysfunction and arterial stiffness on its own. For a CKD patient, this repeated hemodynamic stress from nicotine, whether from a cigarette or a vape, is harmful to the kidneys.
• Other Chemicals: The liquid in e-cigarettes contains numerous other potentially toxic substances, including solvents (propylene glycol, vegetable glycerin), flavorings (like diacetyl), and heavy metals that can leach from the heating coil. The long-term effects of inhaling these aerosolized chemicals on the delicate microvasculature of the kidneys are unknown but are a source of major concern in the nephrology community. They are known to cause inflammation and oxidative stress, the very processes that drive CKD progression.

The Comparison: The key difference is the magnitude and certainty of the harm. The damage from tobacco smoking is catastrophic and well-documented over decades of research. The harm from vaping is significant but likely of a lesser magnitude, though its long-term effects are still being uncovered.

Therefore, the comparison of cessation is as follows:

• Quitting tobacco smoking provides a massive and proven benefit by removing an overwhelming toxic and inflammatory burden from the body. It is one of the single most important things a patient can do to protect their kidneys.
• Quitting vaping also provides a significant and highly probable benefit. It removes the known hemodynamic stress of nicotine and the unknown but likely harmful effects of inhaling a cocktail of other chemicals.

In conclusion, for a patient with CKD, there is no safe level of exposure to either product. While quitting traditional cigarettes offers the largest and most dramatic improvement in their kidney disease trajectory, quitting vaping is also an essential step to remove a significant and unnecessary source of vascular and inflammatory stress from their already vulnerable system.

The Chronic Kidney Disease Solution™ By Shelly Manning It is an eBook that includes the most popular methods to care and manage kidney diseases by following the information provided in it. This easily readable eBook covers up various important topics like what is chronic kidney disease, how it is caused, how it can be diagnosed, tissue damages caused by chronic inflammation, how your condition is affected by gut biome, choices for powerful lifestyle and chronic kidney disease with natural tools etc.

I’m Mr.Hotsia, sharing 30 years of travel experiences with readers worldwide. This review is based on my personal journey and what I’ve learned along the way. I share my experiences on www.hotsia.com